HomeNewsBusinessEarningsBiocon Q3 PAT seen up 106.5% YoY to Rs. 190 cr: Sharekhan

Biocon Q3 PAT seen up 106.5% YoY to Rs. 190 cr: Sharekhan

Net Sales are expected to increase by 32.4 percent Y-o-Y (up 6 percent Q-o-Q) to Rs. 1,400.7 crore, according to Sharekhan.

January 18, 2019 / 14:58 IST
Story continues below Advertisement
Kiran Mazumdar-Shaw | Company: Chairperson, Biocon | Net worth: $4.6 billion | She added $2.22 billion to her wealth, taking her net worth to $4.6 billion in 2020, from $2.38 billion in 2019. It marked the highest gain in percentage terms at 93.28 percent among India's 100 richest persons. (Image: Reuters)
Kiran Mazumdar-Shaw | Company: Chairperson, Biocon | Net worth: $4.6 billion | She added $2.22 billion to her wealth, taking her net worth to $4.6 billion in 2020, from $2.38 billion in 2019. It marked the highest gain in percentage terms at 93.28 percent among India's 100 richest persons. (Image: Reuters)

Sharekhan has come out with its third quarter (October-December’ 18) earnings estimates for the Pharma sector. The brokerage house expects Biocon to report net profit at Rs. 190 crore up 106.5% year-on-year (up 2.2% quarter-on-quarter).

Net Sales are expected to increase by 32.4 percent Y-o-Y (up 6 percent Q-o-Q) to Rs. 1,400.7 crore, according to Sharekhan.

Story continues below Advertisement

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Sharekhan Earnings Estimates - Pharma Sector

Moneycontrol News
first published: Jan 18, 2019 02:58 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!